Group 1 - The core viewpoint of the article highlights the active leverage funds in the A-share market, with financing balances exceeding 1.8 trillion yuan for nine consecutive days as of June 19 [1][4][6] - The pharmaceutical and biological industry continues to attract financing, with a net buying amount exceeding 1.3 billion yuan in the week, while the power equipment, oil and petrochemical, and computer industries also saw significant net buying [2][10][11] - Brokerages are optimistic about the performance of Chinese equity assets in the second half of the year, with foreign capital predicting that these assets will outperform overseas markets [3][12][14] Group 2 - The financing balance in the A-share market has shown fluctuations this year, peaking at 1.9 trillion yuan in mid-March and dropping below 1.8 trillion yuan until June 9, when it rose again [6][8] - From June 9 to June 19, daily financing buying amounts exceeded 100 billion yuan, with June 10 reaching a peak of 126.75 billion yuan [7] - The pharmaceutical sector led the net buying amounts, with a total of 6.244 billion yuan in net buying this month, despite experiencing negative net buying in the last three days of the week [10][9] Group 3 - The power equipment sector recorded a net buying amount of 843 million yuan, while the oil and petrochemical and computer industries followed closely with net buying amounts of 610 million yuan and 603 million yuan, respectively [11] - Various brokerages have released strategies for the second half of 2025, suggesting that the A-share market's central oscillation is expected to gradually rise, driven by fiscal stimulus and improved liquidity [12][13] - Analysts emphasize the importance of domestic consumption and self-sufficiency as key themes for the A-share market in the second half of the year, with a focus on sectors less reliant on imports from the U.S. [14]
资金“爆买”!连续9日,融资余额超1.8万亿元!
券商中国·2025-06-21 15:15